Loading…
OrbusNeich Medical (06929.HK) announced that its wholly-owned subsidiary, OrbusNeich Medical (Zhejiang) Co., Ltd., signed an agreement with Hangzhou Fuchunwan New City Management Committee to invest in a vascular interventional medical device R&D and production base. The project has a fixed asset investment of approximately RMB 300 million, with an annual production capacity of about 2.4 million units after completion.
| Site | Largest | Latest |
|---|---|---|
| Hangzhou Fuchunwan New City, China | $43.5M | 2023-03-28 |